지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한약학회 Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea 제25권 제1호
- 발행연도
- 2002.1
- 수록면
- 1 - 10 (10page)
이용수
초록· 키워드
오류제보하기
Attempts to develop drugs, specific for cancer cells, are dealt here according to the intended cell-target. While many target specific drugs were developed, they reach only moderate successes in clinics for reasons, such as, delivery problem, lack of in vivo efficacy or toxicity. However, recent efforts focusing on the diversity of tyrosine kinases, participating in cell-signal transduction, brought fruit. The first such drug, Givec, approved by the USFDA recently, is used in clinics with great success to threat CML. The drug inhibits tyrosin kinase of bcr-abl, c-abl and v-abl. Work is progressing on other tyrosin kinase inhibitors and on other type of specific cancer cell signal protein inhibitors. These efforts are hoped to yield better cures for cancer in the near future.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Tyrosine Kinase Inhibitors in Ph+ Chronic Myeloid Leukemia Therapy: a Review
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Non-receptor tyrosine kinase inhibitors enhances β-cell survival by suppressing the PKCδ signal transduction pathway in streptozotocin-induced β‐cell apoptosis
한국실험동물학회 학술발표대회 논문집
2015 .08
-
How Can We Treat Cancer Disease Not Cancer Cells?
Cancer Research and Treatment
2017 .01
-
암치료의 새로운 target
KSCO News&Education
2008 .12
-
Molecular Basis of Drug Resistance: Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Anaplastic Lymphoma Kinase Inhibitors
Tuberculosis and Respiratory Diseases
2013 .01
-
Rapid Sequential Gain of ABL1 Kinase Domain Mutations with a Complex Karyotype in the Progression of Chronic Myelogenous Leukemia
Annals of Laboratory Medicine
2014 .01
-
유방암 줄기세포 개념 및 제한점
의생명과학
2018 .01
-
Novel Tumor-Suppressing Signal Pathways: A Window for Target-Specific Anti-Cancer Drug Development
대한약학회 학술대회
2005 .01
-
Endpoint of Cancer Treatment: Targeted Therapies
Asian Pacific journal of cancer prevention : APJCP
2014 .01
-
구강 편평세포암종에서의 암줄기세포 이론과 최신 지견
대한구강악안면외과학회지
2011 .01
-
Future Cancer Therapy with Molecularly Targeted Therapeutics: Challenges and Strategies
Biomolecules & Therapeutics(구 응용약물학회지)
2011 .01
-
난소암에서 c-Abl, c-Kit, Platelet-derived Growth FactorReceptor (PDGFR)-α, PDGFR-β 의 발현과 예후의 관계
Journal of Pathology and Translational Medicine
2006 .01
-
Toxicity of Cancer Chemotherapy
대한외과학회 학술대회 초록집
2012 .11
-
Chemotherapy for Lung Cancer in the Era of Personalized Medicine
Tuberculosis and Respiratory Diseases
2019 .01
-
Coexisting with Clonal Evolution and BCR-ABL Mutant in CML Patients Treated with Second-generation Tyrosine Kinase Inhibitors Predict the Discrepancy of in vitro Drug Sensitivity
Cancer Research and Treatment
2010 .01
-
Chronic Myeloid Leukemia - Prognostic Value of Mutations
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
갑상선암의 병합 표적치료
대한이비인후-두경부외과학회지
2010 .01
-
Current Drugs and Drug Targets in Non-Small Cell Lung Cancer: Limitations and Opportunities
Asian Pacific journal of cancer prevention : APJCP
2015 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0